“We launched our IH-500 NEXT fully automated system for ID-Cards to meet the emerging demands and challenges in the laboratory and health environments,” said Dara Wright, Bio-Rad’s Executive Vice President and President, Clinical Diagnostics Group. “The instrument features optimized result interpretation, providing excellence in grading results, and enhanced cybersecurity. These features are designed to help our customers improve the efficiency and productivity of laboratory testing by reducing costs, meeting increased regulatory demands, and addressing staff shortages.”
The IH-500 NEXT System not only reduces instrument downtime and increases laboratory productivity, but also provides the flexibility and freedom to use high-performing Bio-Rad Reagent Red Blood Cells (RBCs) as well as the lab’s own RBCs or third-party Reagent RBCs.
The IH-500 NEXT System also integrates with Bio-Rad’s antibody identification software, IH-AbID, providing full testing traceability for patient results. The instrument is upgraded to Windows 10 allowing for the installation of the latest compatible security updates.
The IH-500 NEXT System is used with Bio-Rad’s ID-Cards, offering a broad portfolio for both routine testing (type and screen) and specialized testing, including single antigen determination and newborn screening. For more information, please visit bio-rad.com.